Auxolytic

Auxolytic Focuses on Developing Novel Nutrient-Based Control Switches to Address Safety Concerns Associated with Cell Therapies. The company has created a method for manufacturing various types of cell therapies, including pluripotent stem cells and primary human T cells, making these cells dependent on specific nutrients administered for their survival. This represents an entirely new approach to enhancing the safety of cell therapies without compromising the integrity of the original cells. Auxolytic collaborates with companies developing breakthrough cell therapies to improve their products and increase the number of patients who can benefit from them.